Covid Assessment Certificate

ODx's mission is to reduce suffering and tackle antibiotic resistance. We recognise that Covid-19 has had an enormous impact on the health of our global community and is responsible for accelerating the threat of antimicrobial resistance.

That is why we are committed to getting our technology to market as soon as we can. Should this work prove successful, ODx has been advised by medical practitioners that such a device used on urines for ICU and HDU patients being treated for Covid-19 could provide actionable clinical information much faster than existing methods. Not to mention eliminating the need for face to face and repeat GP consultations as well as inpatient bed days.

Our top priority is the safety of future patients, our study participants and employees, and we will continue to closely observe the COVID-19 pandemic and its changing implications. This certificate serves to demonstrate that ODx have followed the Covid-19 secure guidance for working safely during Covid-19 in labs and research facilities issued by the UK Government, and that we have properly assessed risk and taken appropriate measures to mitigate them.

We are all facing this challenge together, and we are doing all that we can at ODx Innovations to support the medical professionals and patients in our region.


ODx Innovations are committed to protecting our employees, clinical trial participants and supporting our healthcare partners to fight COVID-19 and build back better.